Early research (Phase 1)Study completedNCT04403308What this trial is testingONO-7913 Phase I Study (ONO-7913)Who this might be right forSolid Tumor Ono Pharmaceutical Co., Ltd. 7
Testing effectiveness (Phase 2)Ended earlyNCT06198426What this trial is testingIBI3004 in Subjects With Unresectable, Locally Advanced or Metastatic Solid TumorsWho this might be right forSolid Tumor Innovent Biologics (Suzhou) Co. Ltd. 5
Early research (Phase 1)Looking for participantsNCT06545942What this trial is testingStudy of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorProstate Cancer+4 more MOMA Therapeutics 220
Early research (Phase 1)Ended earlyNCT02122146What this trial is testingPF-06664178 In Patients With Advanced Solid TumorsWho this might be right forNeoplasms Pfizer 31
Early research (Phase 1)Not Yet RecruitingNCT05474859What this trial is testingSubjects With Advanced or Metastatic Solid Tumor MalignanciesWho this might be right forMetastatic Solid TumorAdvanced Solid Tumor Xenthera, Inc. 30
Early research (Phase 1)Looking for participantsNCT06234397What this trial is testingDose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid Tumors Hanmi Pharmaceutical Company Limited 216
Early research (Phase 1)Ended earlyNCT05935098What this trial is testingBGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorSolid Tumor BeiGene 99
Testing effectiveness (Phase 2)Study completedNCT03033225What this trial is testingUltrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 StudyWho this might be right forAdvanced Pancreatic CarcinomaLocally Advanced Pancreatic CarcinomaMetastatic Pancreatic Carcinoma+5 more Mayo Clinic 13
Not applicableStudy completedNCT04467593What this trial is testingSafety Study of Whole Body Hyperthermia for Advanced CancerWho this might be right forAdvanced CancerPancreatic Cancer Metastatic ElmediX 16
Early research (Phase 1)Looking for participantsNCT05470348What this trial is testingBL-B01D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid TumorsWho this might be right forBreast CancerSolid Tumor Sichuan Baili Pharmaceutical Co., Ltd. 36
Early research (Phase 1)Looking for participantsNCT06561685What this trial is testingLY4050784 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forMetastatic Solid TumorAdvanced Solid TumorNon-small Cell Lung Cancer+1 more Eli Lilly and Company 340
Early research (Phase 1)Ended earlyNCT04427774What this trial is testingSurufatinib Plus Sintilimab in Patients With Advanced Solid TumorWho this might be right forAdvanced or Metastatic Solid Tumors Innovent Biologics (Suzhou) Co. Ltd. 8
Early research (Phase 1)Study completedNCT05396833What this trial is testingStudy of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320)Who this might be right forMetastatic or Locally Advanced Unresectable Solid Tumors EMD Serono Research & Development Institute, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT00024258What this trial is testingArsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more Memorial Sloan Kettering Cancer Center 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07446725What this trial is testingEvaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid TumorsWho this might be right forAdvanced Solid Tumor Cancer Suzhou Genhouse Bio Co., Ltd. 152
Early research (Phase 1)Looking for participantsNCT07274852What this trial is testingLutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid TumorsWho this might be right forLung CancerBreast CancerHead and Neck Squamous Cell Carcinoma+1 more Sichuan Baili Pharmaceutical Co., Ltd. 22
Early research (Phase 1)Looking for participantsNCT05461768What this trial is testingBL-M07D1 in Patients With Locally Advanced or Metastatic HER2-Positive/Negative Breast Cancer and Other Solid TumorsWho this might be right forBreast CancerLocally Advanced or Metastatic Solid Tumor Sichuan Baili Pharmaceutical Co., Ltd. 348
Testing effectiveness (Phase 2)Active Not RecruitingNCT03611868What this trial is testingAPG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid TumorsWho this might be right forUnresectable or Metastatic Melanoma or Advanced Solid TumorsMelanomaUveal Melanoma+5 more Ascentage Pharma Group Inc. 230
Early research (Phase 1)Study completedNCT01948843What this trial is testingPh 1 ADI-PEG 20 Plus Doxorubicin; Patients With HER2 Negative Metastatic Breast CancerWho this might be right forHER2 Negative Metastatic Breast Cancer Polaris Group 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732What this trial is testingPembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are MetastaticWho this might be right forAdvanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more M.D. Anderson Cancer Center 157